<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04029311</url>
  </required_header>
  <id_info>
    <org_study_id>20170991</org_study_id>
    <nct_id>NCT04029311</nct_id>
  </id_info>
  <brief_title>Comparison of Two Techniques of Combination Therapy for Treatment of Obstructive Sleep Apnea (OSA)</brief_title>
  <official_title>Comparison of Two Techniques of Combination Therapy for Treatment of Obstructive Sleep Apnea (OSA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Joseph Adame</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Adame, J. Michael, D.D.S.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the effects of two combination therapies for patients with obstructive sleep apnea&#xD;
      (OSA) who have been both intolerant to Positive Airway Pressure (PAP) therapy and&#xD;
      sub-therapeutic to oral appliance therapy.&#xD;
&#xD;
      Hypothesis&#xD;
&#xD;
      1. There is a difference between Continuous Positive Airway Pressure (CPAP) vs CPAP/Oral&#xD;
      Appliance (OA) connect vs CPAP/OA disconnected in terms of:&#xD;
&#xD;
        1. Apnea Hypopnea Index (AHI) reduction&#xD;
&#xD;
        2. Amount of side effects&#xD;
&#xD;
        3. Amount of Leaks&#xD;
&#xD;
        4. Hours of use (compliance)&#xD;
&#xD;
        5. CPAP pressure&#xD;
&#xD;
      2. There is a difference between connected and disconnected for the following symptoms:&#xD;
&#xD;
        1. Epworth sleepiness Scale (ESS)&#xD;
&#xD;
        2. Functional Outcomes of Sleep Questionnaire (FOSQ)&#xD;
&#xD;
        3. Side effects Study Design - randomized prospective parallel&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 8, 2017</start_date>
  <completion_date type="Actual">May 7, 2019</completion_date>
  <primary_completion_date type="Actual">February 6, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea-Hypopnea Index</measure>
    <time_frame>2 months</time_frame>
    <description>Episodes per hour that the patient experiences apneas and/or hypopneas</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PAP Pressure</measure>
    <time_frame>2 months</time_frame>
    <description>The pressure required to treat the patient successfully</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Leaks</measure>
    <time_frame>2 months</time_frame>
    <description>The Liters/Minute of leaking of the PAP machine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hours of Use</measure>
    <time_frame>2 months</time_frame>
    <description>The average hours of use per night of each of the combination therapies</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Epworth Sleepiness Scale (ESS)</measure>
    <time_frame>2 months</time_frame>
    <description>The ESS is a self-administered questionnaire with 8 questions. The score can range from 0 to 24. The higher the ESS score, the higher that person's average sleep propensity in daily life.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional Outcomes Sleep Questionnaire (FOSQ)</measure>
    <time_frame>2 months</time_frame>
    <description>FOSQ is a disease specific quality of life questionnaire to determine how sleepiness interferes one's quality of life. The total score range from 5 to 20 (10 questions, 1-4 points per each). The lower values represent a worse quality of life.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intolerance Questionnaire</measure>
    <time_frame>2 months</time_frame>
    <description>This questionnaire consists of 4 questions to determine the frequency of 4 typical side-effects from positive airway pressure therapy. The score ranges from 0 to 16 (4 questions, 0-4 points per each). The higher value represent worse side effects.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Treatment for Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Combination Therapy with Preferred Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preferred Mask refers to a type of existing medical mask used for PAP therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combination Therapy with Custom Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Custom Mask refers to a mask which is supported by an interface which attaches directly to the patient's oral appliance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nuance Pro</intervention_name>
    <description>Study compares Nuance Pro plus Automatic Positive Airway Pressure (autoPAP) vs TAP PAP plus autoPAP</description>
    <arm_group_label>Combination Therapy with Preferred Mask</arm_group_label>
    <other_name>TAP PAP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>autoPAP</intervention_name>
    <description>autoPAP</description>
    <arm_group_label>Combination Therapy with Custom Mask</arm_group_label>
    <arm_group_label>Combination Therapy with Preferred Mask</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TAP PAP</intervention_name>
    <description>TAP PAP</description>
    <arm_group_label>Combination Therapy with Custom Mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Baseline diagnosis AHI &gt; or = 5 plus ESS . or = 10.&#xD;
&#xD;
          -  PAP Intolerance&#xD;
&#xD;
          -  Partial Response to oral appliance therapy: AHI &gt; 5&#xD;
&#xD;
          -  Age: &gt; 18 Exclusion Criteria: History of daily use of alcohol, narcotics or Central&#xD;
             Nervous System (CNS) depressants.&#xD;
&#xD;
          -  Diagnosis of Central Sleep Apnea&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Edentulous&#xD;
&#xD;
          -  Prisoners&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>J. Michael Adame, DDS, PA</name>
      <address>
        <city>Edinburg</city>
        <state>Texas</state>
        <zip>78539</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>July 19, 2019</study_first_submitted>
  <study_first_submitted_qc>July 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2019</study_first_posted>
  <results_first_submitted>February 9, 2021</results_first_submitted>
  <results_first_submitted_qc>March 8, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 2, 2021</results_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Adame, J. Michael, D.D.S.</investigator_affiliation>
    <investigator_full_name>Joseph Adame</investigator_full_name>
    <investigator_title>J. Michael Adame, DDS, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 16, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/11/NCT04029311/Prot_SAP_ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Combination Therapy With Preferred Mask</title>
          <description>Preferred Mask refers to a type of existing medical mask used for Positive Airway Pressure (PAP) therapy.&#xD;
Nuance Pro: Study compares Nuance Pro plus Automatic Positive Airway (autoPAP ) vs TAP PAP plus autoPAP&#xD;
autoPAP: autoPAP</description>
        </group>
        <group group_id="P2">
          <title>Combination Therapy With Custom Mask</title>
          <description>Custom Mask refers to a mask which is supported by an interface which attaches directly to the patient's oral appliance.&#xD;
autoPAP: autoPAP&#xD;
TAP PAP: TAP PAP</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Combination Therapy With Preferred Mask</title>
          <description>Preferred Mask refers to a type of existing medical mask used for PAP therapy.&#xD;
Nuance Pro: Study compares Nuance Pro plus autoPAP vs TAP PAP plus autoPAP&#xD;
autoPAP: autoPAP</description>
        </group>
        <group group_id="B2">
          <title>Combination Therapy With Custom Mask</title>
          <description>Custom Mask refers to a mask which is supported by an interface which attaches directly to the patient's oral appliance.&#xD;
autoPAP: autoPAP&#xD;
TAP PAP: TAP PAP</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="13"/>
            <count group_id="B3" value="28"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.9" spread="12.7"/>
                    <measurement group_id="B2" value="54.5" spread="8.6"/>
                    <measurement group_id="B3" value="56.3" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.4" spread="8.4"/>
                    <measurement group_id="B2" value="32.9" spread="7.5"/>
                    <measurement group_id="B3" value="33.8" spread="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Apnea-Hypopnea Index</title>
        <description>Episodes per hour that the patient experiences apneas and/or hypopneas</description>
        <time_frame>2 months</time_frame>
        <population>Missing data from 1 participant in Combination Therapy with Preferred Mask group</population>
        <group_list>
          <group group_id="O1">
            <title>Combination Therapy With Preferred Mask</title>
            <description>Preferred Mask refers to a type of existing medical mask used for PAP therapy.&#xD;
Nuance Pro: Study compares Nuance Pro plus autoPAP vs TAP PAP plus autoPAP&#xD;
autoPAP: autoPAP</description>
          </group>
          <group group_id="O2">
            <title>Combination Therapy With Custom Mask</title>
            <description>Custom Mask refers to a mask which is supported by an interface which attaches directly to the patient's oral appliance.&#xD;
autoPAP: autoPAP&#xD;
TAP PAP: TAP PAP</description>
          </group>
        </group_list>
        <measure>
          <title>Apnea-Hypopnea Index</title>
          <description>Episodes per hour that the patient experiences apneas and/or hypopneas</description>
          <population>Missing data from 1 participant in Combination Therapy with Preferred Mask group</population>
          <units>episodes/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="3.6"/>
                    <measurement group_id="O2" value="3.6" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>PAP Pressure</title>
        <description>The pressure required to treat the patient successfully</description>
        <time_frame>2 months</time_frame>
        <population>Missing data from 1 participant in Combination Therapy with Preferred Mask group.</population>
        <group_list>
          <group group_id="O1">
            <title>Combination Therapy With Preferred Mask</title>
            <description>Preferred Mask refers to a type of existing medical mask used for PAP therapy.&#xD;
Nuance Pro: Study compares Nuance Pro plus autoPAP vs TAP PAP plus autoPAP&#xD;
autoPAP: autoPAP</description>
          </group>
          <group group_id="O2">
            <title>Combination Therapy With Custom Mask</title>
            <description>Custom Mask refers to a mask which is supported by an interface which attaches directly to the patient's oral appliance.&#xD;
autoPAP: autoPAP&#xD;
TAP PAP: TAP PAP</description>
          </group>
        </group_list>
        <measure>
          <title>PAP Pressure</title>
          <description>The pressure required to treat the patient successfully</description>
          <population>Missing data from 1 participant in Combination Therapy with Preferred Mask group.</population>
          <units>cmH2O</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.6" spread="1.8"/>
                    <measurement group_id="O2" value="8.6" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Leaks</title>
        <description>The Liters/Minute of leaking of the PAP machine</description>
        <time_frame>2 months</time_frame>
        <population>Missing data from 1 participant in Combination Therapy with Preferred Mask group.</population>
        <group_list>
          <group group_id="O1">
            <title>Combination Therapy With Preferred Mask</title>
            <description>Preferred Mask refers to a type of existing medical mask used for PAP therapy.&#xD;
Nuance Pro: Study compares Nuance Pro plus autoPAP vs TAP PAP plus autoPAP&#xD;
autoPAP: autoPAP</description>
          </group>
          <group group_id="O2">
            <title>Combination Therapy With Custom Mask</title>
            <description>Custom Mask refers to a mask which is supported by an interface which attaches directly to the patient's oral appliance.&#xD;
autoPAP: autoPAP&#xD;
TAP PAP: TAP PAP</description>
          </group>
        </group_list>
        <measure>
          <title>Leaks</title>
          <description>The Liters/Minute of leaking of the PAP machine</description>
          <population>Missing data from 1 participant in Combination Therapy with Preferred Mask group.</population>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.1" spread="8.0"/>
                    <measurement group_id="O2" value="16.7" spread="14.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Hours of Use</title>
        <description>The average hours of use per night of each of the combination therapies</description>
        <time_frame>2 months</time_frame>
        <population>Missing data from 1 participant in Combination Therapy with Preferred Mask group.</population>
        <group_list>
          <group group_id="O1">
            <title>Combination Therapy With Preferred Mask</title>
            <description>Preferred Mask refers to a type of existing medical mask used for PAP therapy.&#xD;
Nuance Pro: Study compares Nuance Pro plus autoPAP vs TAP PAP plus autoPAP&#xD;
autoPAP: autoPAP</description>
          </group>
          <group group_id="O2">
            <title>Combination Therapy With Custom Mask</title>
            <description>Custom Mask refers to a mask which is supported by an interface which attaches directly to the patient's oral appliance.&#xD;
autoPAP: autoPAP&#xD;
TAP PAP: TAP PAP</description>
          </group>
        </group_list>
        <measure>
          <title>Hours of Use</title>
          <description>The average hours of use per night of each of the combination therapies</description>
          <population>Missing data from 1 participant in Combination Therapy with Preferred Mask group.</population>
          <units>hours per night</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" spread="1.9"/>
                    <measurement group_id="O2" value="5.9" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Epworth Sleepiness Scale (ESS)</title>
        <description>The ESS is a self-administered questionnaire with 8 questions. The score can range from 0 to 24. The higher the ESS score, the higher that person's average sleep propensity in daily life.</description>
        <time_frame>2 months</time_frame>
        <population>Missing data from 1 participant in Combination Therapy with Preferred Mask group.</population>
        <group_list>
          <group group_id="O1">
            <title>Combination Therapy With Preferred Mask</title>
            <description>Preferred Mask refers to a type of existing medical mask used for PAP therapy.&#xD;
Nuance Pro: Study compares Nuance Pro plus autoPAP vs TAP PAP plus autoPAP&#xD;
autoPAP: autoPAP</description>
          </group>
          <group group_id="O2">
            <title>Combination Therapy With Custom Mask</title>
            <description>Custom Mask refers to a mask which is supported by an interface which attaches directly to the patient's oral appliance.&#xD;
autoPAP: autoPAP&#xD;
TAP PAP: TAP PAP</description>
          </group>
        </group_list>
        <measure>
          <title>Epworth Sleepiness Scale (ESS)</title>
          <description>The ESS is a self-administered questionnaire with 8 questions. The score can range from 0 to 24. The higher the ESS score, the higher that person's average sleep propensity in daily life.</description>
          <population>Missing data from 1 participant in Combination Therapy with Preferred Mask group.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5" spread="4.0"/>
                    <measurement group_id="O2" value="5.8" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Functional Outcomes Sleep Questionnaire (FOSQ)</title>
        <description>FOSQ is a disease specific quality of life questionnaire to determine how sleepiness interferes one's quality of life. The total score range from 5 to 20 (10 questions, 1-4 points per each). The lower values represent a worse quality of life.</description>
        <time_frame>2 months</time_frame>
        <population>Missing data from 1 participant in Combination Therapy with Preferred Mask group.</population>
        <group_list>
          <group group_id="O1">
            <title>Combination Therapy With Preferred Mask</title>
            <description>Preferred Mask refers to a type of existing medical mask used for PAP therapy.&#xD;
Nuance Pro: Study compares Nuance Pro plus autoPAP vs TAP PAP plus autoPAP&#xD;
autoPAP: autoPAP</description>
          </group>
          <group group_id="O2">
            <title>Combination Therapy With Custom Mask</title>
            <description>Custom Mask refers to a mask which is supported by an interface which attaches directly to the patient's oral appliance.&#xD;
autoPAP: autoPAP&#xD;
TAP PAP: TAP PAP</description>
          </group>
        </group_list>
        <measure>
          <title>Functional Outcomes Sleep Questionnaire (FOSQ)</title>
          <description>FOSQ is a disease specific quality of life questionnaire to determine how sleepiness interferes one's quality of life. The total score range from 5 to 20 (10 questions, 1-4 points per each). The lower values represent a worse quality of life.</description>
          <population>Missing data from 1 participant in Combination Therapy with Preferred Mask group.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.3" spread="3.8"/>
                    <measurement group_id="O2" value="36.2" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Intolerance Questionnaire</title>
        <description>This questionnaire consists of 4 questions to determine the frequency of 4 typical side-effects from positive airway pressure therapy. The score ranges from 0 to 16 (4 questions, 0-4 points per each). The higher value represent worse side effects.</description>
        <time_frame>2 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Combination Therapy With Preferred Mask</title>
            <description>Preferred Mask refers to a type of existing medical mask used for PAP therapy.&#xD;
Nuance Pro: Study compares Nuance Pro plus autoPAP vs TAP PAP plus autoPAP&#xD;
autoPAP: autoPAP</description>
          </group>
          <group group_id="O2">
            <title>Combination Therapy With Custom Mask</title>
            <description>Custom Mask refers to a mask which is supported by an interface which attaches directly to the patient's oral appliance.&#xD;
autoPAP: autoPAP&#xD;
TAP PAP: TAP PAP</description>
          </group>
        </group_list>
        <measure>
          <title>Intolerance Questionnaire</title>
          <description>This questionnaire consists of 4 questions to determine the frequency of 4 typical side-effects from positive airway pressure therapy. The score ranges from 0 to 16 (4 questions, 0-4 points per each). The higher value represent worse side effects.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="2.4"/>
                    <measurement group_id="O2" value="3.4" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Combination Therapy With Preferred Mask</title>
          <description>Preferred Mask refers to a type of existing medical mask used for PAP therapy.&#xD;
Nuance Pro: Study compares Nuance Pro plus autoPAP vs TAP PAP plus autoPAP&#xD;
autoPAP: autoPAP</description>
        </group>
        <group group_id="E2">
          <title>Combination Therapy With Custom Mask</title>
          <description>Custom Mask refers to a mask which is supported by an interface which attaches directly to the patient's oral appliance.&#xD;
autoPAP: autoPAP&#xD;
TAP PAP: TAP PAP</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Yasue Tanaka</name_or_title>
      <organization>Tohoku University</organization>
      <phone>+81227178396</phone>
      <email>yasue.tanaka.b3@tohoku.ac.jp</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

